Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, Safety, and Long-Term Outcomes of Shorter (≤ 4 Weeks) Versus Longer (> 4 Weeks) Antibiotic Therapy in Pediatric Empyema Thoracis: A Systematic Review.

Indian pediatrics·2026
Same author

Comparison of Early Intrapleural Fibrinolytic Therapy, Versus Administration After Failure of Intercostal Drainage in Children with Empyema Thoracis: A Systematic Review.

Indian pediatrics·2026
Same author

Activation of TGF-β/ALK5/SMAD signaling alleviates behavioral and neurochemical deficits in tramadol withdrawal.

Toxicology and applied pharmacology·2026
Same author

Transfusion Modalities in Thalassemia Patients: Prophylactic Antigen Matched Versus Usual Matched approach- Experience from Tertiary Care Hospital!

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Clinical Practices for Management of Empyema Thoracis in Children: A Survey of Pediatricians in India.

Indian pediatrics·2026
Same author

Modulation of the AMPK/TFEB Axis by Ezetimibe Attenuates Neuroinflammatory, Oxidative Stress, and Neurotransmitter Dysregulation in Naloxone-precipitated Tramadol Withdrawal in Mice.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026

Related Experiment Video

Updated: Jun 5, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Multi-drug resistant childhood tuberculosis.

Varinder Singh1, Satnam Kaur

  • 1Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children Hospital, Bangla Sahib Marg, New Delhi, 110001, India. 4vsingh@gmail.com

Indian Journal of Pediatrics
|January 4, 2011
PubMed
Summary

Drug resistant tuberculosis in children is a global challenge. Early diagnosis and treatment, even in resource-poor settings, are crucial for successful outcomes in pediatric drug-resistant tuberculosis.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Related Experiment Videos

Last Updated: Jun 5, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Drug-resistant tuberculosis (DR-TB) presents a significant global health challenge.
  • Pediatric tuberculosis (TB) epidemiology, diagnosis, and management, especially DR-TB, are poorly understood.
  • Limited data exists on the epidemiology and treatment outcomes of drug-resistant tuberculosis in children.

Purpose of the Study:

  • To highlight the challenges and strategies for managing drug-resistant tuberculosis in pediatric populations.
  • To emphasize the need for early diagnosis and appropriate treatment for pediatric DR-TB.
  • To identify research gaps in pediatric drug-resistant tuberculosis.

Main Methods:

  • Review of current literature on pediatric drug-resistant tuberculosis.
  • Analysis of challenges in diagnosis and treatment of pediatric MDR-TB.
  • Discussion of existing technologies and strategies for managing pediatric DR-TB.

Main Results:

  • Drug-resistant tuberculosis can be successfully treated in children, even in resource-limited settings.
  • Early drug susceptibility testing is vital for timely diagnosis and effective treatment.
  • Challenges include diagnostic difficulties, drug toxicities, and lack of pediatric formulations.

Conclusions:

  • Effective management of pediatric drug-resistant tuberculosis is achievable with existing technologies.
  • A high index of suspicion and prompt diagnostic testing are essential.
  • Further research is needed for optimal diagnostic tools, treatment regimens, and chemoprophylaxis in pediatric DR-TB.